Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China — Stella
Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(1 site)
China
Peiga Medical Technology (Suzhou) Co., Suzhou, Jiangsu